Group One Trading, L.P. Neoleukin Therapeutics, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.5 - $0.72 $248 - $357	-497 Reduced 24.84%	1,504 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.92 - $2.25 $6,255 - $15,297	-6,799 Reduced 77.26%	2,001 $2,000
Q1 2022 May 12, 2022	BUY	$1.72 - $5.23 $13,932 - $42,363	8,100 Added 1157.14%	8,800 $17,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.75 $3,255 - $5,425	700 New	700 $3,000
Q2 2021 Aug 10, 2021	SELL	$9.23 - $13.12 $923 - $1,312	-100 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$11.26 - $15.78 $1,126 - $1,578	100 New	100 $1,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.